Inflammatory Bowel Syndrome Treatment Market Size, Trends, In-depth Analysis, Research Report Forecast up to 2028: Cosmo Pharmaceuticals and Salix Pharmaceuticals are key players.

The Inflammatory Bowel Syndrome Treatment Market was valued at US$22.529 billion in 2021.

The prime factors propelling the Inflammatory Bowel Syndrome Treatment Market growth are the rising awareness of inflammatory bowel syndrome (IBS) among patients and healthcare professionals.

The Inflammatory Bowel Syndrome Treatment Market will witness robust growth over the projected period.

Inflammatory bowel syndrome (IBS) is a chronic digestive illness affecting the large intestine (colon) and causing symptoms such as stomach pain, bloating, diarrhea, and constipation. The inflammatory bowel syndrome (IBS) treatment provides a wide range of drugs and therapies to control and alleviate the symptoms. The growing prevalence of IBS is a significant factor influencing the growth of the inflammatory bowel syndrome treatment market. In addition, growing awareness against such diseases is also positively impacting overall growth.

Sample request or complete report can be purchased through the link below:
https://www.knowledge-sourcing.com/report/inflammatory-bowel-syndrome-treatment-market

The Inflammatory Bowel Syndrome Treatment Market has been segmented into type, treatment, and geography.

By type, the market has been segmented into irritable bowel syndrome with diarrhea (ibs-d), irritable bowel syndrome with constipation (ibs-c), post-infectious ibs (ibs-pi), and others. Irritable bowel syndrome with constipation will have a significant market share as it is the most common type of inflammatory bowel syndrome.

The market has been segmented by treatment into medications, psychological therapy, dietary supplements, and others. The medication treatment will have a significant market share due to rising new medication establishments and drug discovery in the medical sector. In 2020, the U.S. Food and Drug Administration (FDA) announced that the Tenapanor drug was approved for treating adults with inflammatory bowel syndrome (IBS) and constipation. This shows that the medications will help to boost the Inflammatory Bowel Syndrome Treatment Market growth.

By region, North America is expected to retain a considerable market share due to the high occurrence of the IBS condition in the region and multiple prominent pharmaceutical businesses. According to the Canadian Society of Intestinal Research, IBS is estimated to impact 5% to 20% of Canadians. Furthermore, the region has a robust healthcare system and a high public and professional awareness of IBS, which will drive the overall market growth in the North American region.

The key Inflammatory Bowel Syndrome Treatment Market players are AbbVie Inc., Ironwood Pharmaceuticals, Bayer AG, Probi AB, Salix Pharmaceuticals, and Cosmo Pharmaceuticals.

This Inflammatory Bowel Syndrome Treatment Market has been analyzed into the following segments:

• By Type

o Irritable Bowel Syndrome with Diarrhea (IBS-D)
o Irritable Bowel Syndrome with Constipation (IBS-C)
o Post-infectious IBS (IBS-PI)
o Others

• By Treatment

o Medications
o Psychological therapy
o Dietary Supplements
o Others

• By Geography

o North America

• United States
• Canada
• Mexico

o South America

• Brazil
• Argentina
• Others

o Europe

• United Kingdom
• Germany
• France
• Spain
• Others

o Middle East and Africa

• UAE
• Israel
• Saudi Arabia
• Others

o Asia Pacific

• Japan
• China
• India
• South Korea
• Thailand
• Taiwan
• Indonesia
• Others

Explore More Reports:

• Global Idiopathic Pulmonary Fibrosis Treatment Market: https://www.knowledge-sourcing.com/report/global-idiopathic-pulmonary-fibrosis-treatment-market

• Degenerative Disc Disease Treatment Market: https://www.knowledge-sourcing.com/report/degenerative-disc-disease-treatment-market

Contact Us:

Knowledge Sourcing Intelligence
Phone: +1-850-250-1698
E-Mail: info@knowledge-sourcing.com

Knowledge Sourcing Intelligence (KSI) is a market research and consulting firm publishing market research studies across ten industry verticals. KSI has a team of experienced and young professionals who focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports annually centering on the niche and latest technologies. In addition, we engage with key decision-makers and stakeholders across the value chain to provide clients with a detailed analysis and bird's-eye view of the market with complete market dynamics, statistical forecasts, competitive analysis, key trends, market drivers, and challenges, and strategic recommendations for making informed decisions. Our success lies in our analysts' efforts to meet client expectations by delivering quality work within the stipulated deadlines.

This release was published on openPR.